Homoharringtonine effective in CML patients.
Hitt
Emma
E
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006248:Harringtonines / Q000008:administration & dosage; D000077863:Homoharringtonine; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000473:pathology; D011379:Prognosis; D012307:Risk Factors; D015996:Survival Rate
D006248:Harringtonines; D016898:Interferon-alpha; D000077863:Homoharringtonine